Reken, Germany

Thomas Küper

USPTO Granted Patents = 5 

 

Average Co-Inventor Count = 4.5

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2013-2022

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Thomas Küper: Innovator in Cosmetic and Pharmaceutical Patents

Introduction

Thomas Küper is a notable inventor based in Reken, Germany. He has made significant contributions to the fields of cosmetics and pharmaceuticals, holding a total of five patents. His innovative work focuses on developing products that enhance human health and well-being.

Latest Patents

Küper's latest patents include a cooling product that features cosmetic and sanitary products comprising physiologic cooling compounds, selected 1,2-alkanediols, and tensides and/or UV filters. Another significant patent involves polyhydroxylated pentacyclic triterpene acids as HMG-CoA reductase inhibitors. This invention relates to certain polyhydroxylated pentacyclic triterpene acids for use in the prophylactic and therapeutic treatment of diseases that respond to a reduction of HMG-CoA reductase activity in mammals, particularly humans. The invention also encompasses mixtures and plant extracts containing euscaphic acid and tormentic acid, along with formulations that include these compounds.

Career Highlights

Throughout his career, Thomas Küper has worked with prominent companies such as Symrise AG and Prairie Berry Europe GmbH. His experience in these organizations has allowed him to refine his skills and contribute to innovative projects in the industry.

Collaborations

Küper has collaborated with notable colleagues, including Heiko Oertling and Sabine Lange. These partnerships have fostered a creative environment that encourages the development of groundbreaking inventions.

Conclusion

Thomas Küper's work exemplifies the spirit of innovation in the fields of cosmetics and pharmaceuticals. His patents reflect a commitment to improving health and well-being through scientific advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…